Corteva (CTVA) Q1 2025 earnings summary

Executive summary

• Q1 2025 net sales declined 2% to $4.42B, but organic sales rose 3% on strong demand for new products, hybrids, and technology platforms, driving double-digit EBITDA growth and margin expansion.

• GAAP income from continuing operations was $667M, up 77% year-over-year, with EPS of $0.97, and operating EBITDA increased 15% to $1.19B, reflecting operational excellence and cost discipline.

• Both Seed and Crop Protection segments achieved double-digit EBITDA growth, supported by pricing, volume gains in new products and biologicals, and productivity improvements.

• Full-year 2025 guidance reaffirmed, with expectations for double-digit earnings growth, continued margin expansion, and ~$1B in share repurchases.

• Record demand for grain, oilseeds, and biofuels continues, with steady on-farm demand for premium crop input technologies.

Financial highlights

• Q1 2025 net sales were $4.4B, down 2% year-over-year, with organic sales up 3%; Seed net sales $2.71B (down 2%, organic up 2%), Crop Protection $1.71B (down 2%, organic up 3%).

• Operating EBITDA rose 15% to $1.19B, with margin up 390 bps to 26.9%; Seed segment EBITDA $842M (up 13%), Crop Protection $377M (up 22%).

• GAAP EPS was $0.97 (up 83%); operating EPS $1.13 (up 27%).

• Free cash flow for Q1 was negative due to seasonal working capital, but FY 2025 guidance is $1.4B–$1.8B.

• Over $200M in cost savings realized from lower raw material costs and productivity.

Outlook and guidance

• FY 2025 operating EBITDA expected at $3.6B–$3.8B (10% growth at midpoint), margin guidance 21.0–21.5%, and net sales $17.2B–$17.6B.

• Operating EPS guidance of $2.70–$2.95; free cash flow conversion targeted at 40–45% of EBITDA.

• $1B in share repurchases planned for 2025.

• Tariff impacts estimated at $50M for 2025, with mitigation actions underway.

• Guidance assumes no extreme weather, major operational disruptions, or significant macroeconomic shocks.